EUVIMEDEUVIMED entdecken
Open Access

Stem cell models of TAFAZZIN deficiency reveal novel tissue-specific pathologies in Barth syndrome

Olivia Sniezek Carney iD, Kodi W Harris, Yvonne Wohlfarter, Kyuna Lee, Grant Butschek, Arianna F Anzmann, Anne Hamacher-Brady, Markus A Keller, Hilary J Vernon iD

Human Molecular Genetics · 2025

DOI: 10.1093/hmg/ddae152 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Molecular Genetics, 2025. Verfasst von Olivia Sniezek Carney und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetic Medicine, Johns Hopkins University School of Medicine, 733 North Broadway, Baltimore, MD 21205, United States. Hauptthemen laut MEDLINE: Barth Syndrome, Transcription Factors. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS, Maryland TEDCO, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Barth syndrome (BTHS) is a rare mitochondrial disease caused by pathogenic variants in the gene TAFAZZIN, which leads to abnormal cardiolipin (CL) metabolism on the inner mitochondrial membrane. Although TAFAZZIN is ubiquitously expressed, BTHS involves a complex combination of tissue specific phenotypes including cardiomyopathy, neutropenia, skeletal myopathy, and growth delays, with a relatively minimal neurological burden. To understand both the developmental and functional effects of TAZ-deficiency in different tissues, we generated isogenic TAZ knockout (TAZ-KO) and WT cardiomyocytes (CMs) and neural progenitor cells (NPCs) from CRISPR-edited induced pluripotent stem cells (iPSCs). In TAZ-KO CMs we discovered evidence of dysregulated mitophagy including dysmorphic mitochondria and mitochondrial cristae, differential expression of key autophagy-associated genes, and an inability of TAZ-deficient CMs to properly initiate stress-induced mitophagy. In TAZ-deficient NPCs we identified novel phenotypes including a reduction in CIV abundance and CIV activity in the CIII2&CIV2 intermediate complex. Interestingly, while CL acyl chain manipulation was unable to alter mitophagy defects in TAZ-KO CMs, we found that linoleic acid or oleic acid supplementation was able to partially restore CIV abundance in TAZ-deficient NPCs. Taken together, our results have implications for understanding the tissue-specific pathology of BTHS and potential for tissue-specific therapeutic targeting. Moreover, our results highlight an emerging role for mitophagy in the cardiac pathophysiology of BTHS and reveal a potential neuron-specific bioenergetic phenotype.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Barth SyndromeTranscription FactorsHumansInduced Pluripotent Stem CellsMyocytes, CardiacAcyltransferasesNeural Stem CellsMitochondriaMitophagyCardiolipinsAnimalsMice

Stichwörter der Autor:innen

Barth syndromeTAFAZZINcardiomyopathymitophagy

Substanzen

AcyltransferasesTAFAZZIN protein, humanTranscription FactorsCardiolipins

Autor:innen und Institutionen

  • Department of Genetic Medicine, Johns Hopkins University School of Medicine, 733 North Broadway, Baltimore, MD 21205, United States.
  • Institute of Human Genetics, Medical University of Innsbruck, Peter-Mayr-Str. 1/1.OG, Innsbruck 6020, Austria.
  • Department of Molecular Microbiology and Immunology, Johns Hopkins University Bloomberg School of Public Health, 615 North Wolfe Street, Baltimore, MD 21205, United States.

ORCID-Profile: Olivia Sniezek Carney, Hilary J Vernon

Förderung

  • NIGMS
  • Maryland TEDCO
  • NIGMS NIH HHS
  • National Heart, Lung, and Blood Institute of the National Institutes of Health
  • NHLBI NIH HHS

Zitieren

APA

Sniezek Carney, O., Harris, K. W., Wohlfarter, Y., Lee, K., Butschek, G., Anzmann, A. F., Hamacher-Brady, A., Keller, M. A., & Vernon, H. J. (2025). Stem cell models of TAFAZZIN deficiency reveal novel tissue-specific pathologies in Barth syndrome. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddae152

Vancouver

Sniezek Carney O, Harris KW, Wohlfarter Y, Lee K, Butschek G, Anzmann AF, et al. Stem cell models of TAFAZZIN deficiency reveal novel tissue-specific pathologies in Barth syndrome. Human Molecular Genetics. 2025. doi:10.1093/hmg/ddae152

BibTeX
@article{SniezekCarney2025,
  author = {Sniezek Carney, Olivia and Harris, Kodi W and Wohlfarter, Yvonne and Lee, Kyuna and Butschek, Grant and Anzmann, Arianna F and Hamacher-Brady, Anne and Keller, Markus A and Vernon, Hilary J},
  title = {Stem cell models of TAFAZZIN deficiency reveal novel tissue-specific pathologies in Barth syndrome},
  journal = {Human Molecular Genetics},
  year = {2025},
  doi = {10.1093/hmg/ddae152}
}
Kostenlos starten →